0.65
price up icon1.72%   0.011
 
loading
Metavia Inc stock is traded at $0.65, with a volume of 84,179. It is up +1.72% in the last 24 hours and down -7.14% over the past month. MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$0.639
Open:
$0.64
24h Volume:
84,179
Relative Volume:
0.33
Market Cap:
$15.73M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.56%
1M Performance:
-7.14%
6M Performance:
-59.47%
1Y Performance:
+0.00%
1-Day Range:
Value
$0.6106
$0.655
1-Week Range:
Value
$0.6065
$0.66
52-Week Range:
Value
$0.5555
$2.75

Metavia Inc Stock (MTVA) Company Profile

Name
Name
Metavia Inc
Name
Phone
(857) 702-9600
Name
Address
545 CONCORD AVENUE, CAMBRIDGE
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MTVA's Discussions on Twitter

Compare MTVA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MTVA
Metavia Inc
0.65 15.74M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Metavia Inc Stock (MTVA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-30-24 Initiated H.C. Wainwright Buy

Metavia Inc Stock (MTVA) Latest News

pulisher
Aug 20, 2025

Candlestick Signal Suggests Reversal in MetaVia Inc.July 2025 Earnings & Weekly Stock Performance Updates - thegnnews.com

Aug 20, 2025
pulisher
Aug 20, 2025

Is it time to cut losses on MetaVia Inc.2025 Market Sentiment & Daily Profit Focused Screening - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Visual analytics tools that track MetaVia Inc. performance2025 Pullback Review & Weekly Market Pulse Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Using data models to predict MetaVia Inc. stock movementJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Chart overlay techniques for tracking MetaVia Inc.Portfolio Performance Summary & Real-Time Volume Spike Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

MetaVia Inc. stock daily chart insightsMarket Risk Report & Reliable Price Breakout Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is MetaVia Inc. stock poised for growthWeekly Trade Report & AI Forecasted Entry and Exit Points - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to interpret RSI for MetaVia Inc. stockEarnings Performance Report & Accurate Buy Signal Notifications - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Market reaction to MetaVia Inc.’s recent newsWeekly Risk Report & High Conviction Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

MetaVia Inc. stock chart pattern explained2025 Dividend Review & Community Driven Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can you recover from losses in MetaVia Inc.July 2025 Reactions & Community Supported Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can MetaVia Inc. hit a new high this monthJuly 2025 Retail & Real-Time Chart Pattern Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Momentum divergence signals in MetaVia Inc. chartTrade Signal Summary & Entry Point Strategy Guides - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Multi asset correlation models including MetaVia Inc.Market Weekly Review & Intraday High Probability Setup Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Will MetaVia Inc. outperform the market2025 Retail Activity & Long-Term Safe Investment Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

MetaVia Inc. Building a Base Near SupportEarnings Overview Summary & Free Safe Entry Trade Signal Reports - mustnews.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

MetaVia Inc. stock volume spike explained2025 Volatility Report & AI Powered Market Trend Analysis - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Applying big data sentiment scoring on MetaVia Inc.Portfolio Update Summary & Short-Term Trading Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Analyzing recovery setups for MetaVia Inc. investors2025 Top Decliners & Intraday High Probability Alerts - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

What institutional flow reveals about MetaVia Inc.Trade Volume Report & Technical Entry and Exit Tips - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Using Python tools to backtest MetaVia Inc. strategiesGlobal Markets & Stepwise Trade Execution Plans - Newser

Aug 17, 2025

Metavia Inc Stock (MTVA) Financials Data

There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Metavia Inc Stock (MTVA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
DONG-A ST CO., LTD
10% Owner
May 08 '25
Buy
0.71
4,647,887
3,300,000
9,995,679
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):